DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Wedbush Maintains Outperform on Macrogenics, Raises Price Target to $16

Wedbush maintains Macrogenics (NASDAQ:MGNX) with a Outperform and raises the price target from $14 to $16.

Benzinga · 01/21/2020 13:03

Wedbush maintains Macrogenics (NASDAQ:MGNX) with a Outperform and raises the price target from $14 to $16.